Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
GlaxoSmithKline Australia
Administration route
Intramuscular injection
Vaccine group
Combination vaccines
Description:
Registered as a booster in people aged ≥4 years.
dTpa — diphtheria-tetanus-acellular pertussis combination vaccine (reduced antigen formulation)
Each 0.5 mL pre-filled syringe contains:
- ≥2 IU Diphtheria toxoid1
- ≥20 IU Tetanus toxoid1
- 8 µg Pertussis toxoid1
- 8 µg Filamentous Haemagglutinin1
- 2.5 µg Pertactin1
1. Adsorbed onto 0.5 mg aluminium as aluminium hydroxide and aluminium phosphate.
Also contains traces of:
- bovine derived materials
For Product Information and Consumer Medicine Information about Boostrix vaccine visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Related diseases
Page history
Last updated
Last reviewed